| Drugs with this side effect as MedDRA Preferred Term
			
			
	  	5-ASA
				
			Anidulafungin
				
				
					Bronchospasm: postmarketing BPTI
				
			CAS 76095-16-4
				
			CAS 76420-72-9
				
				
					Bronchospasm: postmarketing Cancidas
				
			Colimycin M
				
			Fe(III
				
				
					Bronchospasm: postmarketing Gd-DTPA
				
			Insulin
				
			K779
				
				
					BronchospasmBronchoconstrictionLantus
				
			Lisinopril
				
				
					Bronchospasm: very rare, postmarketing Lutalyse
				
			Mersyndol
				
			N-acetylcysteine
				
			Nuvocid
				
			Octreotide
				
			Optison
				
				
					Bronchospasm: postmarketing PGE2
				
				
					BronchospasmBronchoconstrictionPhotofrin
				
			Refludan
				
			T-A2-3
				
			acebutolol
				
			acetaminophen
				
			acipimox
				
			adenosine
				
				
					Bronchospasm: postmarketing Bronchoconstrictionalfentanil
				
			allopurinol
				
				
					Bronchospasm: postmarketing amiodarone
				
				
					Bronchospasm: postmarketing amphotericin B
				
				
					Bronchospasm: postmarketing argenine vasopressin
				
			atenolol
				
			atovaquone
				
				
					Bronchospasm: postmarketing, 2% atracurium
				
			azelastine
				
			azithromycin
				
				
					Bronchospasm: postmarketing aztreonam
				
			beclomethasone
				
				
					Bronchospasm: postmarketing beclomethasone dipropionate
				
			beclomethasone monopropionate
				
			benzonatate
				
			betahistine
				
			betaxolol
				
				
					Bronchospasm: postmarketing bethanechol
				
			bisoprolol
				
				
					Bronchospasm: postmarketing, uncommon, 0% bleomycin hydrochloride
				
			bortezomib
				
			bosentan
				
			bromhexine
				
			budesonide
				
				
					Bronchospasm: postmarketing, 2% Bronchoconstrictionbupivacaine
				
			buprenorphine
				
			bupropion
				
				
					Bronchospasm: postmarketing, rare capecitabine
				
			captopril
				
			carboplatin
				
			carteolol
				
			carvedilol
				
			cefotaxime
				
				
					Bronchospasm: postmarketing ceftazidime
				
			ceftriaxone
				
			celecoxib
				
				
					BronchospasmBronchospasm aggravatedceliprolol
				
			cetirizine
				
				
					Bronchospasm: 1.9% - 3.1% cevimeline
				
				
					BronchospasmBronchoconstrictionciclesonide
				
			cilazapril
				
			ciprofloxacin
				
				
					Bronchospasm: postmarketing cisatracurium
				
			citalopram
				
			clodronate
				
			clomipramine
				
			clopidogrel
				
				
					Bronchospasm: postmarketing cyclizine
				
			cyclophosphamide
				
				
					Bronchospasm: postmarketing dabigatran etexilate
				
			dalbavancin
				
			dasatinib
				
			desflurane
				
				
					Bronchospasm: postmarketing dexmedetomidine
				
				
					Bronchospasm: postmarketing diatrizoate
				
			diclofenac
				
			dicloxacillin
				
			diflunisal
				
			dihydroergotamine
				
			dipyridamole
				
			docetaxel
				
			dolasetron
				
			dorzolamide
				
				
					Bronchospasm: postmarketing doxapram
				
			doxazosin
				
				
					BronchospasmBronchospasm aggravated: postmarketing doxycycline
				
			droperidol
				
			ertapenem
				
			esmolol
				
			esomeprazole magnesium
				
				
					Bronchospasm: postmarketing estradiol
				
			etodolac
				
				
					Bronchospasm: postmarketing etoposide
				
			etoposide phosphate
				
			etoricoxib
				
				
					Bronchospasm: postmarketing etravirine
				
			everolimus
				
			famotidine
				
			fentanyl
				
			ferumoxytol
				
				
					Bronchospasm: postmarketing flecainide
				
			flucloxacillin
				
			flunisolide
				
			fluorescein
				
				
					Bronchospasm: postmarketing, rare fluoxetine
				
			fluticasone
				
				
					Bronchospasm: postmarketing fluticasone propionate
				
				
					Bronchospasm: very rare, postmarketing, rare fluticasone/salmeterol
				
				
					Bronchospasm: postmarketing, rare folate
				
			formoterol
				
				
					Bronchospasm: postmarketing, rare, uncommon foscarnet
				
			fosinopril
				
			fosinoprilat
				
			gabapentin
				
			gadobenate dimeglumine
				
				
					Bronchospasm: postmarketing gadodiamide
				
			gadolinium
				
				
					Bronchospasm: postmarketing gadopentetate
				
			gadoversetamide
				
			ganciclovir
				
				
					Bronchospasm: postmarketing gatifloxacin
				
			gemcitabine
				
				
					Bronchospasm: uncommon Allergic bronchospasm: 2% haloperidol
				
				
					Bronchospasm: very rare, postmarketing hepatitis B vaccines
				
			hetastarch
				
				
					Bronchospasm: postmarketing histamine
				
			hydromorphone
				
			hydroxychloroquine
				
			ibandronate
				
				
					Bronchospasm: postmarketing Bronchoconstrictionibuprofen
				
			icodextrin
				
				
					Bronchospasm: postmarketing ifosfamide
				
				
					Bronchospasm: postmarketing iloprost
				
				
					Bronchospasm: postmarketing indacaterol
				
			insulin detemir
				
			iodixanol
				
			iohexol
				
			iopamidol
				
			iopromide
				
				
					Bronchospasm: postmarketing iotrolan
				
			ioversol
				
			ioxaglate
				
			ioxilan
				
			ipratropium bromide
				
				
					Bronchospasm: postmarketing, uncommon, 2.3% - 5.4% BronchoconstrictionBronchospasm aggravated: 0.7% - 1% iron sucrose
				
			isoflurane
				
			isomannide
				
			isoproterenol
				
			isosorbide-5-mononitrate
				
			itraconazole
				
			ketoprofen
				
			ketorolac
				
				
					Bronchospasm: postmarketing ketorolac tromethamine
				
				
					Bronchospasm: postmarketing labetalol
				
			lamotrigine
				
			lercanidipine
				
			levobunolol
				
			lidocaine
				
			lomefloxacin
				
			loxapine
				
			mannitol
				
			maprotiline
				
			maraviroc
				
			medroxyprogesterone acetate
				
			meloxicam
				
			melphalan
				
			memantine
				
			meprobamate
				
			metaproterenol
				
			methacholine
				
				
					BronchospasmBronchoconstrictionmethohexital
				
			methylprednisolone
				
			methylprednisolone sodium succinate
				
			metoclopramide
				
				
					Bronchospasm: postmarketing metoprolol
				
				
					Bronchospasm: postmarketing, rare, uncommon midazolam
				
			milrinone
				
				
					Bronchospasm: postmarketing minocycline
				
			misoprostol
				
				
					Bronchospasm: postmarketing mivacurium
				
			moexiprilat
				
			mometasone
				
				
					Bronchospasm: postmarketing mometasone furoate
				
			morphine
				
				
					Bronchospasm: postmarketing moxifloxacin
				
			nadolol
				
			nafcillin
				
			nalbuphine
				
			nebivolol
				
				
					Bronchospasm: postmarketing nelfinavir
				
				
					Bronchospasm: postmarketing neostigmine
				
				
					Bronchospasm: postmarketing nicotine
				
			nifedipine
				
			nizatidine
				
			nystatin
				
			ofatumumab
				
			ofloxacin
				
				
					Bronchospasm: postmarketing olsalazine
				
			omeprazole
				
				
					Bronchospasm: postmarketing, rare ondansetron
				
				
					Bronchospasm: postmarketing, 0.595% orlistat
				
				
					Bronchospasm: postmarketing oxacillin
				
			oxaliplatin
				
			oxcarbazepine
				
			oxprenolol
				
			oxycodone
				
				
					BronchospasmBronchoconstrictionoxymorphone
				
			pamidronate
				
			pancuronium
				
			parecoxib
				
			penicillin
				
			pentamidine
				
			pentostatin
				
			pentoxifylline
				
			perindopril
				
			perindopril erbumine
				
			phosphate
				
			pilocarpine
				
			pindolol
				
			piroxicam
				
			prilocaine
				
			propofol
				
			propranolol
				
			quinidine
				
			ramipril
				
			ranitidine
				
			rasburicase
				
			regadenoson
				
			remifentanil
				
			retinoic acid
				
				
					Bronchospasm: postmarketing ribavirin
				
				
					BronchospasmBronchoconstrictionrifabutin
				
			rifapentine
				
			rimantadine
				
			risperidone
				
			rivastigmine
				
			rocuronium
				
			rofecoxib
				
			ropivacaine
				
				
					Bronchospasm: 0.1% - 1.5% roxithromycin
				
			salbutamol
				
				
					Bronchospasm: very rare, postmarketing, 8% - 18% Bronchospasm aggravated: postmarketing salmeterol
				
			salmon calcitonin acetate
				
				
					Bronchospasm: postmarketing salsalate
				
			sertraline
				
				
					Bronchospasm: postmarketing, rare, infrequent sevoflurane
				
				
					Bronchospasm: postmarketing sodium
				
				
					Bronchospasm: postmarketing sodium cromoglycate
				
			sodium iothalamate
				
			sotalol
				
			succinylcholine
				
			sufentanil
				
			sugammadex
				
			sulindac
				
			sumatriptan
				
				
					Bronchospasm: postmarketing technetium-99m
				
			telmisartan
				
			teniposide
				
			terconazole
				
				
					Bronchospasm: postmarketing tetrofosmin
				
			thalidomide
				
			timolol
				
			tinidazole
				
			tobramycin
				
			tramadol
				
			trans 4-cyclohexyl-L-proline
				
			trifluoperazine
				
			tropicamide
				
			tropisetron
				
				
					Bronchospasm: postmarketing, 0% - 1.03% trovafloxacin
				
			v 1784
				
				
					Bronchospasm: postmarketing, 4.9% - 5% valdecoxib
				
			vandetanib
				
			vasopressin
				
			vecuronium
				
			verapamil
				
			vinflunine
				
			vinorelbine
				
			zanamivir
				
				
					Bronchospasm: postmarketing zoledronic acid
				
				
					Bronchospasm: postmarketing Bronchoconstriction: postmarketing, uncommon zolmitriptan
				
			zolpidem
				
			 | Drugs with this indication |